XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
  Hearing Imapirment
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

ENT Channel
subscribe to ENT newsletter

Latest Research : ENT

   DISCUSS   |   EMAIL   |   PRINT
Antibiotic telithromycin linked to liver damage
Jan 22, 2006 - 2:18:00 PM, Reviewed by: Dr. Priya Saxena

Telithromycin (Ketek) was approved by the US Food and Drug Administration in 2004.

 
An antibiotic drug to treat lung and sinus infections has been found to cause liver failure, according to a report.

Doctors at the Carolinas Medical Center in Charlotte, North Carolina, studied three patients who were administered the drug 'Ketek' and found liver failure in them, a report published in the journal Annals of Internal Medicine says.

All three cases occurred within a few months of each other last year, said report co-author John Hanson, a liver transplant doctor at the medical centre.

'Ketek' is prescribed to treat lung and sinus infections. The antibiotic also led to the death of a 26-year-old man and transplant surgery for a 51-year-old woman, it reported.

Ketek was approved by the US Food and Drug Administration in 2004. Doctors have sent their findings to the FDA and discussed them with Sanofi-Aventis SA, which makes Ketek.

The company is currently reviewing the data, the report said.
 

- Indo-Asian News Service
 

 
Subscribe to ENT Newsletter
E-mail Address:

 



Related ENT News

UK researcher identifies brain region responsible for spatial hearing
Boosting local immunity in nose can help treat chronic sinusitis
Acidic mammalian chitinase gene linked to recurrent sinusitis
Beta-actin mutations linked to deafness and dystonia
Role of Folic Acid in Treatment of Laryngeal Leucoplakia
Hyperactivity, attention deficit, sleepiness, and ADHD often improves after tonsillectomy - Study
New vaccine against ear infection
Middle cranial fossa approach preserves hearing in acoustic neuroma patients
Aldosterone linked to good hearing as we age
Antibiotic telithromycin linked to liver damage


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us